Jayne David R.W. has filed 3 insider transactions across 1 company since May 2024.
Most recent transaction: a grant/award of 12135 shares of Aurinia Pharmaceuticals Inc. ($AUPH) on November 21, 2024.
Activity breakdown: 0 open-market purchases and 1 sale.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nov. 21, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Jayne David R.W. | Director | A | Common Shares | 12135 | $0.00 | 56,499.0000 | 145,651,000 | 27.35% | 0.01% |
| Nov. 21, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Jayne David R.W. | Director | A | Director Stock Option (right to buy) | 18641 | $0.00 | 18,641.0000 | 145,651,000 | 9999.99% | 0.01% |
| May 21, 2024 | Aurinia Pharmaceuticals Inc. | $AUPH | Jayne David R.W. | Director | S | Common Stock | 4946 | $5.74 | 44,364.0000 | 143,236,000 | 10.03% | 0.00% |